It appears Eli Lilly has applied for permission to enable single patient access to retatrutide on a per case basis prior to full FDA approval of retatrutide. Normally this is reserved for cancer or other rare or difficult to treat diseases. So WTH is Eli Lilly doing with this unprecedented step?
